Patent-settlement expenditure treated as commercially expedient revenue outlay, with foreign-law restrictions inapplicable before the prospective amen...
International transaction benchmarking restricts transfer pricing adjustments to associated-enterprise dealings, while functional comparability govern...
Joint development agreements defer taxable transfer where possession lacks part performance, while completed flats determine consideration and exempti...
The High Court upheld the penalty imposed u/s 112(a) of the Customs Act, 1962 on the Appellant. The Court found the order cryptic and non-speaking, violating principles of natural justice. The CESTAT and Commissioner concluded that the appellants were abettors in a fraud scheme involving Ascorbic Acid. The Commissioner determined that the Managing Director played an active role in the fraud, resulting in substantial loss to Government Revenue. The CESTAT confirmed these findings, stating no substantial question of law arises. The appeal was dismissed, affirming the abetment of duty evasion.
The High Court upheld the penalty imposed u/s 112(a) of the Customs Act, 1962 on the Appellant. The Court found the order cryptic and non-speaking, violating principles of natural justice. The CESTAT and Commissioner concluded that the appellants were abettors in a fraud scheme involving Ascorbic Acid. The Commissioner determined that the Managing Director played an active role in the fraud, resulting in substantial loss to Government Revenue. The CESTAT confirmed these findings, stating no substantial question of law arises. The appeal was dismissed, affirming the abetment of duty evasion.
Note: It is a system-generated summary and is for quick reference only.